Desmopressin responsiveness by age in type 1 von Willebrand disease

Abstract Background Patients with type 1 von Willebrand disease (VWD) undergo a desmopressin (DDAVP) responsiveness challenge at diagnosis to assess whether DDAVP reverses their coagulation deficits. Current practice assumes DDAVP responsiveness remains constant over the lifetime. In patients with t...

Full description

Bibliographic Details
Published in:Research and Practice in Thrombosis and Haemostasis
Main Authors: Nicola Goldberg, Rosane Nisenbaum, Hong Song, David Lillicrap, Jerome Teitel, Paula James, Michelle Sholzberg
Format: Article
Language:English
Published: Elsevier 2020-08-01
Subjects:
Online Access:https://doi.org/10.1002/rth2.12354